PMID: 8026152Jan 1, 1994Paper

Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level

Diagnostic Microbiology and Infectious Disease
C E GrantJ A Williams

Abstract

Bloodstream (224) and urine (nine) isolates of coagulase-negative staphylococci (CNS) were evaluated using MicroScan Pos ID and Rapid Pos ID panels. A modification of the conventional method of Kloos and Schleifer served as the reference method. The isolates were selected to include a broad range of CNS species, including 44 S. epidermidis, 50 S. hominis, 39 S. warneri, 33 S. capitis, 21 S. haemolyticus, 12 S. simulans, 11 S. saprophyticus, six S. cohnii, five S. lugdunensis, three S. xylosus, four S. auricularis, two S. schleiferi, two S. intermedius, and one S. sciuri. The Pos ID panel had an overall rate of agreement (correct plus probably correct) with the reference method of 79%, including 95% for S. epidermidis, 95% for S. haemolyticus, 64% for S. hominis, 67% for S. simulans, 79% for S. warneri, and 100% for S. saprophyticus. The Rapid Pos ID panel had an overall rate of agreement (correct plus probably correct) of 76%, including 91% for S. epidermidis, 90% for S. haemolyticus, 64% for S. hominis, 58% for S. simulans, 77% for S. warneri, and 100% for S. saprophyticus. Both systems are acceptable for the identification of the clinically significant species S. haemolyticus, S. saprophyticus, and S. epidermidis, but are les...Continue Reading

References

Oct 1, 1991·Antimicrobial Agents and Chemotherapy·T L BannermanW E Kloos
Oct 1, 1991·Journal of Clinical Pathology·K F BarkerA Bhargava
Jan 1, 1990·The Journal of Infectious Diseases·R S SchwalbeP H Gilligan
Nov 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M SkulnickD E Low
Jun 1, 1989·Annals of Internal Medicine·P Collignon
Apr 9, 1987·The New England Journal of Medicine·R S SchwalbeP H Gilligan
Oct 1, 1984·The American Journal of Medicine·S Ponce de Leon, R P Wenzel

❮ Previous
Next ❯

Citations

Aug 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L PatteetM Ieven
Oct 29, 1998·Diagnostic Microbiology and Infectious Disease·K B WaitesB L Zimmer
Oct 4, 2008·Journal of Clinical Microbiology·Tomasz Hauschild, Srdjan Stepanovic
Mar 30, 2002·Journal of Clinical Microbiology·Michel Drancourt, Didier Raoult
Aug 6, 2005·Journal of Clinical Microbiology·Philippe GiammarinaroRegine Talon
Aug 15, 2009·Journal of Microbiological Methods·Sylvain OrengaDavid H Pincus
Aug 29, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T MonsenJ Wiström
Sep 8, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C DupontE Carbonnelle
Nov 5, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shota YonetaniTakashi Watanabe
Jan 16, 2007·Revista Do Instituto De Medicina Tropical De São Paulo·Geraldo dos Santos OliveiraFrancisco de Assis Baroni
Mar 12, 2005·Memórias do Instituto Oswaldo Cruz·Maria de Lourdes R S CunhaLiciana V A Silveira
Apr 2, 2011·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Jeong Hwan ShinYeong Hoon Kim
Oct 7, 2011·Expert Review of Anti-infective Therapy·Elizabeth Babu, John Oropello
Dec 1, 1996·Journal of Clinical Microbiology·F MartineauM G Bergeron

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.